Protagonist Therapeutics, Inc. (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

101.68

+4.59 (4.73%)

At close: Mar 19, 2026, 4:00 PM EDT

101.99

+0.31 (0.30%)

Pre-market: Mar 20, 2026, 8:08 AM EDT

Protagonist Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	128.39	97.25	186.73	125.74	123.67
Short-Term Investments	438.97	321.66	154.89	111.61	203.24
Cash & Short-Term Investments	567.36	418.91	341.62	237.36	326.9
Cash Growth	35.44%	22.63%	43.93%	-27.39%	6.90%
Other Receivables	0.12	165	10	0.01	4.36
Total Trade Receivables	0.12	165	10	0.01	4.36
Other Current Assets	10.09	7.73	3.96	5.71	9.48
Total Current Assets	577.57	591.64	355.58	243.08	340.74
Net Property, Plant & Equipment	11.69	12.61	2.15	4.63	6.73
Long-Term Investments	78.64	140.25	-	-	-
Other Long-Term Assets	0.29	0.23	0.23	0.23	0.23
Total Assets	668.19	744.73	357.95	247.93	347.7
Accounts Payable	5.34	1.62	0.78	3.71	2.5
Accrued Expenses	28.27	23.69	19.36	24.96	37.72
Current Portion of Leases	2.28	0.51	1.14	2.52	2.2
Unearned Revenue	9.55	18.89	-	-	1.6
Other Current Liabilities	-	2.69	-	-	-
Total Current Liabilities	45.44	47.4	21.27	31.18	44.02
Long-Term Leases	8.04	10.36	-	1.14	3.66
Other Long-Term Liabilities	-	11.68	-	-	-
Total Long-Term Liabilities	8.04	22.03	-	1.14	3.66
Total Liabilities	53.48	69.43	21.27	32.32	47.67
Common Stock	0	0	0	0	-
Additional Paid-in Capital	1,085	1,016	952.49	752.72	709.68
Accumulated Other Comprehensive Income	0.64	-0.08	-0.11	-0.36	-0.3
Retained Earnings	-470.67	-340.52	-615.71	-536.76	-409.36
Shareholders' Equity	614.71	675.3	336.68	215.61	300.02
Total Liabilities & Equity	668.19	744.73	357.95	247.93	347.7
Total Debt	10.32	10.87	1.14	3.66	5.86
Net Cash (Debt)	557.04	408.05	340.48	233.7	321.04
Net Cash Growth	36.51%	19.85%	45.69%	-27.21%	7.07%
Net Cash Per Share	8.76	6.27	6.00	4.76	6.93
Book Value	614.71	675.3	336.68	215.61	300.02
Book Value Per Share	9.67	10.38	5.93	4.40	6.48
Tangible Book Value	614.71	675.3	336.68	215.61	300.02
Tangible Book Value Per Share	9.67	10.38	5.93	4.40	6.48

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q